Moderna | MRNA - Cash And Equivalent


Moderna reported $2.6B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Acadia Pharmaceuticals USD 819.69M 27.33M Dec/2025
Agios Pharmaceuticals USD 89.13M 3.58M Dec/2025
Alnylam Pharmaceuticals USD 1.66B 167M Dec/2025
Amgen USD 9.13B 316M Dec/2025
Arrowhead Research USD 201.64M 112.94M Dec/2025
Biogen USD 3.01B 854.3M Dec/2025
BioMarin Pharmaceutical USD 1.31B 61.57M Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Gilead Sciences USD 7.33B 2.19B Sep/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Incyte USD 3.58B 650.78M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 2.6B 1.46B Dec/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Puma Biotechnology USD 53.52M 1.14M Sep/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 202.51M 36.4M Sep/2025
United Therapeutics USD 1.56B 217M Dec/2025
Vertex Pharmaceuticals USD 6.61B 321.1M Dec/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025